EMA Guidance On Redacting Commercially Confidential Info In Clinical Reports Nears
This article was originally published in SRA
Executive Summary
The European Medicines Agency is close to finalizing two eagerly-awaited guidance documents that will help drug companies comply with requirements relating to the agency's new policy on proactively publishing clinical trial data1.